A, local puffer application of PACAP, indicated by arrow, could initiate a slow depolarization in the cardiac neurones. In many cells, a burst of action potentials was generated during the rising phase of the depolarization. B, in the same cell as in A, membrane excitability was enhanced following PACAP application as evidenced by the increased number of action potentials elicited by a similar 1 s suprathreshold depolarizing current pulse as given prior to peptide application. C, local puffer application of substance P, indicated by arrow consistently initiated a slow depolarization. D, in the same cell as C, there was no change in excitability (determined using a similar 1 s suprathreshold depolarizing current pulse) evident following substance P application. E, the mean amplitude of the depolarization produced in different cells by PACAP or substance P was similar. However, the range of depolarization was noticeably greater for PACAP than for substance P. F, a graph demonstrating that after PACAP application, the number of action potentials elicited by 1 s depolarizing current pulses increased with increasing stimulus strength. Data points represent mean ±s.e.m. from 10 cells following PACAP application (•). In contrast, prior to peptide application or following substance P application (n= 9 cells, ▴), the number of action potentials produced did not change markedly with increasing stimulus strength. The control curve is the average response obtained from 18 cells prior to peptide application (▾). The asterisks indicate that the number of action potentials produced was significantly greater following PACAP application than prior to peptide application.